
Validea's Patient Investor model, based on Warren Buffett's strategy, assigned Manhattan Associates (MANH), a large-cap supply chain software provider, a 72% rating. Although MANH passed key fundamental tests including earnings predictability, debt service, return on equity, and free cash flow, its score falls below the 80% threshold typically indicating interest for this value-oriented strategy, notably failing criteria related to retained earnings use and initial rate of return. This suggests MANH exhibits robust operational characteristics but may not currently present a compelling deep value opportunity according to this specific investment framework, despite its strong underlying business.
Manhattan Associates (MANH) scores a 72% on Validea's Patient Investor model, which is based on Warren Buffett's investment principles. This score indicates a fundamentally sound company that does not fully align with the strategy's core requirements, as it falls below the 80% threshold that typically signals interest. The analysis reveals a company with strong operational characteristics, passing key tests for earnings predictability, debt service, return on equity, return on total capital, and free cash flow. Furthermore, the company's share repurchase activity is viewed favorably. However, the model flags two significant weaknesses: the company's 'Use of Retained Earnings' and its 'Initial Rate of Return'. The failure on the initial return metric suggests that, despite its quality, the stock's current valuation is not considered attractive enough to provide the margin of safety sought by this value-oriented strategy. The 'Use of Retained Earnings' failure implies that the firm may not be reinvesting its profits at a sufficiently high rate of return, a critical aspect of Buffett's long-term compounding philosophy.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment